Systematic Evidence Review Number 21

Screening and Interventions for Overweight and Obesity in Adults

File Inventory


Prepared by:

Research Triangle Institute
3040 Cornwallis Road
P.O. Box 12194
Research Triangle Park, NC 27709

Kathleen McTigue, M.D., M.P.H.
Russell Harris, M.D., M.P.H.
M. Brian Hemphill, M.D.
Audrina J. Bunton, B.A.
Linda J. Lux, M.P.A.
Sonya Sutton, B.S.P.H.
Kathleen N. Lohr, Ph.D.


File Name	Description			Software	Version		File	Size
_____________________________________________________________________________________________________
01report.doc	Microsoft Word® Document	MS Word®		2002	2.3MB	129 pages
 Contents: Cover, Title Page, Preface, Acknowledgments, Structured Abstract, Table of Contents;
 Chapter 1. Introduction: Background, Cost of Obesity and Overweight, Prior Recommendations 
  About Obesity Screening, Organization of This Review, Table 1. Ranges of Body Mass Index with 
  Minimal Absolute Risk for Mortality in Men and Women, Figure 1. Cardiovascular Morbidity in Men, 
  Figure 2. Cardiovascular Morbidity in Women, Figure 3. All-cause Mortality in Men: Studies with 
  Race Differentials, Figure 4. All-cause Mortality in Women: Studies with Race Differentials;
 Chapter 2. Methods: Analytic Framework and Key Questions, Literature Search Strategy and Synthesis, 
  Article Review and Data Abstraction, Preparation of this Systematic Evidence Review, 
  Table 2. Screening for Obesity: Key Questions, Table 3. Screening for Obesity: Inclusion Criteria 
  and Results of Searches, Table 4. Summary of Findings from Prior Systematic Reviews and Our Updated 
  Searches of Obesity Treatment Efficacy, Figure 5. Analytic Framework: Screening and Interventions 
  for Overweight and Obesity in Adults;
 Chapter 3. Results: Key Question No. 1: Does Screening for Overweight and Obesity Affect Health 
  Outcomes?, Key Question No. 2: What is the Prevalence of Overweight and Obesity?, Key Question No. 3: 
  Is There a Reliable and Valid Screening Test?, Key Question No. 4a: Do Any Interventions Lead to 
  Sustained Weight Reduction?, Key Question No. 4b: Do Interventions Improve Other Intermediate 
  Health Outcomes?, Key Question No. 5: Do Interventions Improve Final Health Outcomes?, Key Question 
  No. 6: What are the Harms of Screening and Treatment?, Figure 6. Differences in Mean Weight Loss 
  between Intervention and Control Groups for Counseling and Behavioral Interventions, 
  Figure 7. Differences in Mean Weight Loss Between Intervention and Control Groups for Pharmacotherapy 
  Interventions, Figure 8. Frequency of 10% Weight Loss for Pharmacotherapy Interventions 
  (Sibutramine and Orlistat);
 Chapter 4. Discussion: General Conclusions, Cross-cutting Findings and Future Research Issues;
 References, Appendix A. Evidence Tables, Appendix B. Counseling Intervention Descriptions, 
 Appendix C. Descriptions of Intensive Counseling and Behavioral Intervention Studies
_____________________________________________________________________________________________________

Current as of December 2003


Internet Citation:

Screening and Interventions for Overweight and Obesity in Adults. File Inventory, Systematic Evidence Review Number 21. December 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/prev/obesinv.htm.


Return to Preventive Services Files Download
U.S. Preventive Services Task Force
AHRQ Home Page
Department of Health and Human Services